Testicular Cancer Management: Imaging, Staging, and Treatment for Seminoma Versus Non-Seminoma
Aditya Bagrodia, MD, FACS, UC San Diego Health, and David Ambinder, MD, Urology Resident, New York Medical College/Westchester Medical Center, provide an overview of the care continuum for a newly diagnosed testicular cancer patient. What kinds of imaging should be done? How does initial staging and diagnosis affect early treatment (or surveillance) plans? Do the approaches differ for seminoma versus non-seminoma, and how likely is the patient to be cured?
Пікірлер: 1
Very helpful. I don’t know if you’re responding to these but I found I had Stage 1A. Tumor less than 4cm (3.7) with RTI but nothing else. I am trying to decide between carboplatin or going surveillance. The way it’s been communicated to me is that I could go from 80% cured to 95%+ cured. I know you can’t say for definite one way or the other but I’d rather not have chemotherapy if I don’t need it but should I have it if I can increase the cure rate?